Clinical Trial

TACE With Thermosensitive Nanogel Versus Embosphere for HCC

Name: TACE With Thermosensitive Nanogel Versus Embosphere for HCC — clinical trial record (NCT06593964)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated September 19, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

To verify the safety and efficacy of TACE withThermosensitive Nanogel Embolic Agent for HCC.

Trial Details

NCT Number	NCT06593964
Lead Sponsor	Zhongda Hospital
Conditions	Unresectable Hepatocellular Carcinoma
Enrollment	188 participants
Start Date	2024-09-10
Primary Completion	2026-04-30 (estimated)
Study Completion	2026-04-30 (estimated)
Updated on ClinicalTrials.gov	2024-09-19